Temozolomide + Thalidomide
From OncoWiki
Indication
Metastatic cancer
- Temozolomide (Temodar) 75 mg/m2 po qd x 6 wks every 8 wks
- Thalidomide (Thalomid) 100-400 mg po qd
- Thalidomide is classified as an immunomodulatory agent, and an antiangiogenic agent.